אדריבלסטינה 50 מ"ג PFS

Land: Israel

Sprache: Hebräisch

Quelle: Ministry of Health

Wirkstoff:

DOXORUBICIN HYDROCHLORIDE 50 MG / 25 ML

Verfügbar ab:

PFIZER PHARMACEUTICALS ISRAEL LTD

ATC-Code:

L01DB01

Darreichungsform:

SOLUTION FOR INJECTION

Verabreichungsweg:

I.V

Hergestellt von:

ACTAVIS ITALY S.P.A

Therapiegruppe:

DOXORUBICIN

Anwendungsgebiete:

Adriblastina has been used successfully to produce regression in a variety of neoplastic conditions, such as carcinoma of the breast, lung, bladder, thyroid, and also ovarian carcinomas, bone and soft-tissue sarcomas, Hodgkin's and non- Hodgkin's lymphomas, neuroblastomas, Wilms tumour, acute lymphoblastic leukaemia and acute myeloblastic leukaemia

Berechtigungsdatum:

2013-01-01